The Alphabet Soup of Pneumonia: CAP, HAP, HCAP, NHAP, and VAP

 

 Buy Article Permissions and Reprints

ABSTRACT

The classification of pneumonia is increasingly complex as the patient population becomes more diverse. More and more patients are identified with pneumonia attributed to multidrug-resistant (MDR) bacteria, occurring both in the hospital setting and outside of the hospital. This is likely related to the expanding pool of patients at risk for colonization with MDR bacteria. These expanding patient populations include individuals residing in nonhospital health care facilities (e.g., long-term nursing facilities, assisted living environments, rehabilitation centers), patients undergoing outpatient procedures or therapies (hemodialysis, wound care, infusion therapy), patients who have been recently discharged from the hospital setting, and those with significant underlying immunosuppression. Patients exposed to these nonhospital risks who develop pneumonia have traditionally been categorized as having community-acquired pneumonia (CAP). However, the new designation for pneumonia acquired in these environments is healthcare-associated pneumonia (HCAP). Additionally, some authors have categorized patients in nursing homes as developing nursing home–acquired pneumonia (NHAP) because there may be distinct epidemiological associations with this infection. Although HCAP is currently treated with the same protocols as CAP in many hospitals, recent evidence indicates that HCAP differs from CAP with respect to pathogens and prognosis, and in fact, more closely resembles hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) requiring broader empirical antimicrobial therapy than CAP.

REFERENCES

• 1 Hiramatsu K, Niederman M S. Healthcare-associated pneumonia: a new therapeutic paradigm.  Chest. 2005;  128 3784-3787
  CrossrefPubMedGoogle Scholar
• 2 Kollef M H, Shorr A, Tabak Y P, Gupta V, Liu L Z, Johannes R S. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia.  Chest. 2005;  128 3854-3862
  CrossrefPubMedGoogle Scholar
• 3 American Thoracic Society; Infectious Diseases Society . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.  Am J Respir Crit Care Med. 2005;  171 388-416
  CrossrefPubMedGoogle Scholar
• 4 Mandell L A, Wunderink R G, Anzueto A et al.. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.  Clin Infect Dis. 2007;  44(Suppl 2) S27-S72
  CrossrefPubMedGoogle Scholar
• 5 Craven D E. What is healthcare-associated pneumonia, and how should it be treated?.  Curr Opin Infect Dis. 2006;  19 153-160
  PubMedGoogle Scholar
• 6 National hospital ambulatory medical care survey: 2004 emergency department summary. Available at http://www.cdc.gov/nchs/data/ad/ad372.pdf Accessed April 2, 2007
  Google Scholar
• 7 Friedman N D, Kaye K S, Stout J E et al.. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.  Ann Intern Med. 2002;  137 791-797
  CrossrefPubMedGoogle Scholar
• 8 Muder R R, Aghababian R V, Loeb M B, Solot J A, Higbee M. Nursing home-acquired pneumonia: an emergency department treatment algorithm.  Curr Med Res Opin. 2004;  20 1309-1320
  CrossrefPubMedGoogle Scholar
• 9 Houck P M, Bratzler D W, Nsa W, Ma A, Bartlett J G. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.  Arch Intern Med. 2004;  164 637-644
  CrossrefPubMedGoogle Scholar
• 10 Iregui M, Ward S, Sherman G, Fraser V J, Kollef M H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.  Chest. 2002;  122 262-268
  CrossrefPubMedGoogle Scholar
• 11 Luna C M, Vujacich P, Niederman M S et al.. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.  Chest. 1997;  111 676-685
  CrossrefPubMedGoogle Scholar
• 12 Micek S T, Kollef K E, Reichley R M, Roubinian N, Kollef M H. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience.  Antimicrob Agents Chemother. 2007;  51 3568-3573
  CrossrefPubMedGoogle Scholar
• 13 Shorr A F, Tabak Y P, Killian A D, Gupta V, Liu L Z, Kollef M H. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.  Crit Care Med. 2006;  34 2588-2595
  CrossrefPubMedGoogle Scholar
• 14 Guay D R. Guidelines for the management of adults with healthcare-associated pneumonia: implications for nursing facility residents.  Consult Pharm. 2006;  21 719-725
  PubMedGoogle Scholar
• 15 Tablan O C, Anderson L J, Besser R, Bridges C, Hajjeh R. Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.  MMWR Recomm Rep. 2004;  53(RR-3) 1-36
  PubMedGoogle Scholar
• 16 Kirk O, Glenthoj J, Dragsted U B et al.. Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital.  Dan Med Bull. 2001;  48 84-88
  PubMedGoogle Scholar
• 17 Grossman R F, Rotschafer J C, Tan J S. Antimicrobial treatment of lower respiratory tract infections in the hospital setting.  Am J Med. 2005;  118(Suppl 7A) 29S-38S
  CrossrefPubMedGoogle Scholar
• 18 Pop-Vicas A E, D'Agata E M. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.  Clin Infect Dis. 2005;  40 1792-1798
  CrossrefPubMedGoogle Scholar
• 19 Lescure F X, Locher G, Eveillard M et al.. Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care.  Infect Control Hosp Epidemiol. 2006;  27 1213-1218
  CrossrefPubMedGoogle Scholar
• 20 Fujitani S, Yu V L. A new category: healthcare-associated pneumonia: a good idea, but problems with its execution.  Eur J Clin Microbiol Infect Dis. 2006;  25 627-631
  CrossrefPubMedGoogle Scholar
• 21 Wunderink R G. Healthcare-associated bacteremia: stirring the mud.  Crit Care Med. 2006;  34 2685-2686
  CrossrefPubMedGoogle Scholar
• 22 Tillotson G S, Ball P. Meeting report: Fourth Forum on Respiratory Tract Infections, Sitges, Spain, 8 11 February 2007.  J Antimicrob Chemother. 2007;  60 464-469
  CrossrefPubMedGoogle Scholar
• 23 Arancibia F, Bauer T T, Ewig S et al.. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis.  Arch Intern Med. 2002;  162 1849-1858
  CrossrefPubMedGoogle Scholar
• 24 Carratalà J, Mykietiuk A, Fernández-Sabé N et al.. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.  Arch Intern Med. 2007;  167 1393-1399
  CrossrefPubMedGoogle Scholar
• 25 Lim W S, Macfarlane J T. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia.  Eur Respir J. 2001;  18 362-368
  CrossrefPubMedGoogle Scholar
• 26 Marrie T J, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia.  J Am Geriatr Soc. 1997;  45 50-55
  PubMedGoogle Scholar
• 27 El Solh A A, Pietrantoni C, Bhat A, Bhora M, Berbary E. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.  Clin Infect Dis. 2004;  39 474-480
  CrossrefPubMedGoogle Scholar
• 28 Muder R R. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention.  Am J Med. 1998;  105 319-330
  CrossrefPubMedGoogle Scholar
• 29 Craven D E, Palladino R, McQuillen D P. Healthcare-associated pneumonia in adults: management principles to improve outcomes.  Infect Dis Clin North Am. 2004;  18 939-962
  CrossrefPubMedGoogle Scholar
• 30 Buising K L, Thursky K A, Black J F et al.. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia.  Thorax. 2006;  61 419-424
  CrossrefPubMedGoogle Scholar
• 31 Capelastegui A, Espana P P, Quintana J M et al.. Validation of a predictive rule for the management of community-acquired pneumonia.  Eur Respir J. 2006;  27 151-157
  CrossrefPubMedGoogle Scholar
• 32 Ewig S, Ruiz M, Mensa J et al.. Severe community-acquired pneumonia: assessment of severity criteria.  Am J Respir Crit Care Med. 1998;  158 1102-1108
  CrossrefPubMedGoogle Scholar
• 33 Fine M J, Auble T E, Yealy D M et al.. A prediction rule to identify low-risk patients with community-acquired pneumonia.  N Engl J Med. 1997;  336 243-250
  CrossrefPubMedGoogle Scholar
• 34 Ewig S, Torres A. Severe community-acquired pneumonia.  Clin Chest Med. 1999;  20 575-587
  CrossrefPubMedGoogle Scholar
• 35 Micek S T, Dunne M, Kollef M K. Complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production.  Chest. 2005;  128 2732-2738
  CrossrefPubMedGoogle Scholar
• 36 Falagas M E, Karveli E A, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections.  Eur J Clin Microbiol Infect Dis. 2007;  26 857-868
  CrossrefPubMedGoogle Scholar
• 37 Rello J, Bodi M, Mariscal D et al.. Microbiological testing and outcome of patients with severe community-acquired pneumonia.  Chest. 2003;  123 174-180
  CrossrefPubMedGoogle Scholar
• 38 Arancibia F, Bauer T T, Ewig S et al.. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis.  Arch Intern Med. 2002;  162 1849-1858
  CrossrefPubMedGoogle Scholar
• 39 Ibrahim E H, Ward S, Sherman G, Schaiff R, Fraser V J, Kollef M H. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia.  Crit Care Med. 2001;  29 1109-1115
  CrossrefPubMedGoogle Scholar
• 40 Soo Hoo G W, Wen Y E, Nguyen T V, Goetz M B. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia.  Chest. 2005;  128 2778-2787
  CrossrefPubMedGoogle Scholar

Marin H KollefM.D. 

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine

660 South Euclid Ave., Campus Box 8052, St. Louis, MO 63110

Email: mkollef@im.wustl.edu